Dx developer Singulex files $86.25M IPO; Ex-Orthofix manager charged with health care fraud;

 @FierceMedDev: Terumo renewed its license of some crucial stent tech from Biosensors International. More | Follow @FierceMedDev

 @MarkHFierce: An FDA panel supports approval for Second Sight's retinal prosthesis. More | Follow @MarkHFierce

 @DamianFierce: API producer Cedarsburg Hauser is expanding its capabilities and betting on a boom in CMO demand. More | Follow @DamianFierce

> California diagnostics developer Singulex has filed for an $86.25 million IPO. The San Francisco Business Times reports that the company is also promising a test to measure heart disease at levels that weren't possible before. Story

> What does Medtronic's ($MDT) buyout of China Kanghui Holdings mean for other devicemakers trying to get a foothold in China? Report

> ConvaTec has closed its $321 million acquisition of catheter-maker 180 Medical. News

> California's LoneStar Heart has enrolled its first patient in a worldwide safety and efficacy test for Algisyl-LVR, an implantable biopolymer to treat heart failure. Release

> Covidien ($COV) is showcasing its Sonicision cordless ultrasonic dissection device and iDrive Ultra powered stapling system at the annual American College of Surgeons convention in Chicago. More

> SafeStitch Medical has begun shipping its new hernia fixation device, four months after its initial commercial launch. Release

> A former territory manager for Orthofix has been charged with health-care fraud regarding an alleged scheme to submit $250,000 in fraudulent claims for bone-growth stimulator devices that fell short of Medicare guidelines. Story

Biotech News

 @FierceBiotech: TDM-1's impressive survival rate puts Roche and Genentech on track for FDA approval. More | Follow @FierceBiotech

 @JohnCFierce: MIT finance wiz calls for $30B megafund to back next-gen cancer drugs. More | Follow @JohnCFierce

 @RyanMFierce: Amid hunt for partnerships, AstraZeneca hits the blogosphere with LabTalk. More | Follow @RyanMFierce

> Ariad grabs spotlight at ESMO with 'compelling' results for lung cancer drug. Article

> Bayer, Evotec join forces on $765M endometriosis drug partnership. Item

> MIT financial wiz calls for $30B megafund to back next-gen cancer drugs. Story

Pharma News

@FiercePharma: In Europe, J&J's injectable wins approval + gets AML-in-elderly use. More | Follow @FiercePharma

> Herceptin data fends off $1.5B threat to Roche sales. News

> Abbott exec can take comfort in Mylan CEO's degree travails. Article

> Pfizer's Xalkori, Roche's TDM-1 among winners at ESMO. Story

CRO News

> Quintiles considering small acquisitions, CEO says. News

> FDA taps CRO Vince & Associates for $5M bioequivalent contract. Story

> FDA now in charge of clinical trial transparency. Article

> Cedarburg Hauser bets on API boom with plant expansion. Item

Biotech IT News

> AstraZeneca hits the blogosphere with LabTalk. Story

> Genomics outfit puts genetic tests on computers. News

> ChemAxon opens shop in 'heart' of Boston biotech hub. Article

> Medidata advances clinical trials software use in Japan. Item

 

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.